Suppr超能文献

表型评分相关的意义有助于外显子组测序分析中变异的优先级排序。

Significance Associated with Phenotype Score Aids in Variant Prioritization for Exome Sequencing Analysis.

机构信息

Bionano Genomics, San Diego, California.

Center for Personalized Medicine, Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California.

出版信息

J Mol Diagn. 2024 May;26(5):337-348. doi: 10.1016/j.jmoldx.2024.01.009. Epub 2024 Feb 13.

Abstract

Several in silico annotation-based methods have been developed to prioritize variants in exome sequencing analysis. This study introduced a novel metric Significance Associated with Phenotypes (SAP) score, which generates a statistical score by comparing an individual's observed phenotypes against existing gene-phenotype associations. To evaluate the SAP score, a retrospective analysis was performed on 219 exomes. Among them, 82 family-based and 35 singleton exomes had at least one disease-causing variant that explained the patient's clinical features. SAP scores were calculated, and the rank of the disease-causing variant was compared with a known method, Exomiser. Using the SAP score, the known causative variant was ranked in the top 10 retained variants for 94% (77 of 82) of the family-based exomes and in first place for 73% of these cases. For singleton exomes, the SAP score analysis ranked the known pathogenic variants within the top 10 for 80% (28 of 35) of cases. The SAP score, which is independent of detected variants, demonstrates comparable performance with Exomiser, which considers both phenotype and variant-level evidence simultaneously. Among 102 cases with negative results or variants of uncertain significance, SAP score analysis revealed two cases with a potential new diagnosis based on rank. The SAP score, a phenotypic quantitative metric, can be used in conjunction with standard variant filtration and annotation to enhance variant prioritization in exome analysis.

摘要

已经开发了几种基于计算机的注释方法,用于在外显子组测序分析中对变体进行优先级排序。本研究引入了一种新的度量标准——与表型相关的显着性 (Significance Associated with Phenotypes, SAP) 评分,该评分通过比较个体的观察表型与现有的基因-表型关联来生成统计评分。为了评估 SAP 评分,对 219 个外显子组进行了回顾性分析。其中,82 个基于家族的外显子组和 35 个单体外显子组至少有一个致病变异可以解释患者的临床特征。计算了 SAP 评分,并将致病变异的排名与已知方法 Exomiser 进行了比较。使用 SAP 评分,对于 94%(82 个中的 77 个)基于家族的外显子组,已知的致病变异在排名前 10 的保留变异中排名第 10,对于其中 73%的病例排名第 1。对于单体外显子组,SAP 评分分析将已知的致病性变异排在前 10 位,占 80%(35 个中的 28 个)的病例。SAP 评分不依赖于检测到的变异,与同时考虑表型和变异级别的证据的 Exomiser 具有可比的性能。在 102 个结果为阴性或变异意义不确定的病例中,SAP 评分分析根据排名揭示了两个具有潜在新诊断的病例。SAP 评分,一种表型定量度量,可以与标准变异过滤和注释结合使用,以增强外显子组分析中的变异优先级排序。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验